Improving diagnosis and management of Alpha-1 antitrypsin deficiency in primary care: Translating knowledge into action

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 7, Issue 3, 2010, Pages 192-198

  Fromer, Leonard ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alpha 1 antitrypsin deficiency; Diagnosis; Emphysema; Primary Care

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; ALPHA 1 ANTITRYPSIN; TRYPSIN INHIBITOR;

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ASTHMA; AWARENESS; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; DISEASE SEVERITY; EARLY DIAGNOSIS; EMPHYSEMA; FAMILY HISTORY; FOLLOW UP; GENETIC RISK; HUMAN; LUNG DISEASE; LUNG FUNCTION; MALE; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCREENING; SMOKING CESSATION; ALPHA 1-ANTITRYPSIN DEFICIENCY; ATTITUDE TO HEALTH; COMPLICATION; DIFFERENTIAL DIAGNOSIS; FORCED EXPIRATORY VOLUME; INTRAVENOUS DRUG ADMINISTRATION; LIVER TRANSPLANTATION; LIVING DONOR; LUNG FUNCTION TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; PRIMARY HEALTH CARE; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

ADULT; ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; DIAGNOSIS, DIFFERENTIAL; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFUSIONS, INTRAVENOUS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; PREDICTIVE VALUE OF TESTS; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; TRYPSIN INHIBITORS;

EID: 77952788983     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2010.482577     Document Type: Review

References (22)

1. Janoff A. Inhibition of human granulocyte elastase by serum alpha-1-antitrypsin. Am Rev Respir Dis 1972; 105:121-122.
2. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2003; 168:818-900.
3. Demeo DL, Silverman EK. Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk. Thorax 2004; 59:259-264.
4. Seersholm N, Kok-Jensen A, Dirksen A. Decline in FEV1 among patients with severe hereditary alpha 1-antitrypsin deficiency type PiZ. Am J Respir Crit Care Med 1995; 152:1922-1925.
5. Campos MA, Wanner A, Zhang G, Sandhaus RA. Trends in the diagnosis of symptomatic patients with alpha1-antitrypsin deficiency between 1968 and 2003. Chest 2005; 128:1179-1186.
6. Stoller JK, Aboussouan LS. Alpha1-antitrypsin deficiency. Lancet 2005; 365:2225-2236.
7. Stoller JK, Fromer L, Brantly M, Stocks J, Strange C. Primary care diagnosis of alpha-1 antitrypsin deficiency: issues and opportunities. Cleve Clin J Med 2007; 74:869-874.
8. Rosenthal TC. The medical home: growing evidence to support a new approach to primary care. J Am Board Fam Med 2008; 21:427-440.
9. de Serres FJ, Blanco I, Fernandez-Bustillo E. Estimating the risk for alpha-1 antitrypsin deficiency among COPD patients: evidence supporting targeted screening. COPD 2006; 3:133-139.
10. Fleming LE, Oquendo S, Bean JA, Tamer R, Finn S, Wanner A. Pilot detection study of alpha(1) antitrypsin deficiency in a targeted population. Am J Med Genet 2001; 103:69-74.
11. Luisetti M, Massi G, Massobrio M, Guarraci P, Menchicchi FM, Beccaria M, Balbi B. A national program for detection of alpha 1-antitrypsin deficiency in Italy. Gruppo I.D.A. Respir Med 1999; 93:169-172.
12. Bals R, Koczulla R, Kotke V, Andress J, Blackert K, Vogelmeier C. Identification of individuals with alpha-1-antitrypsin deficiency by a targeted screening program. RespirMed 2007; 101: 1708-1714.
13. Martinez FJ, Raczek AE, Seifer FD, Conoscenti CS, Curtice TG, D'Eletto T, Cote C, Hawkins C, Phillips AL. Development and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS). COPD 2008; 5:85-95.
14. Rahaghi F, Ortega I, Rahaghi N, Oliveira E, Ramirez J, Smolley L, Stoller JK. Physician alert suggesting alpha-1 antitrypsin deficiency testing in pulmonary function test (PFT) results. COPD 2009; 6:26-30.
15. Needham M, Stockley RA. Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history. Thorax 2004; 59:441-445.
16. Wewers MD, Casolaro MA, Sellers SE, Swayze SC, McPhaul KM, Wittes JT, Crystal RG. Replacement therapy for alpha 1- antitrypsin deficiency associated with emphysema. N Engl J Med 1987; 316:1055-1062.
17. Seersholm N, Wencker M, Banik N, Viskum K, Dirksen A, Kok- Jensen A, Konietzko N. Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group. Eur Respir J 1997; 10:2260-2263.
18. The Alpha-1-Antitrypsin Deficiency Registry Study Group. Survival and FEV1 decline in individuals with severe deficiency of alpha 1-antitrypsin. Am J Respir Crit Care Med 1998; 158:49-59.
19. Wencker M, Banik N, Buhl R, Seidel R, Konietzko N. Longterm treatment of alpha1-antitrypsin deficiency-related pulmonary emphysema with human alpha1-antitrypsin. Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL)-alpha1-AT-study group. Eur Respir J 1998; 11:428-433.
20. Dirksen A, Dijkman JH, Madsen F, Stoel B, Hutchinson DC, Ulrik CS, Skovgaard LT, Kok-Jensen A, Rudolphus A, Seersholm N, Vrooman HA, Reiber JH, Hansen NC, Heckscher T, Viskum K, Stolk J. A randomized clinical trial of alpha 1- antitrypsin augmentation therapy. Am J Respir Crit CareMed 1999; 160:1468-1472.
21. Dirksen A, Piitulainen E, Parr DG, Deng C, Wencker M, Shaker SB, Stockley RA. Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiency. Eur Respir J 2009; 33:1345-1353.
22. Stockley RA, Deng C, Piitulainen E, Parr DG, Shaker SB, Wencker M, Stolk J, Stoel BC, Dirksen A. Therapeutic efficacy of alpha-1 antitrypsin (AAT) augmentation therapy on the loss of lung tissue: an integrated analysis [abstract]. Am J Respir Crit Care Med Apr 2008; 177.